MorphoSys is a German biopharmaceutical company developing antibody-based treatments for cancer and autoimmune diseases. It was acquired by Novartis in 2024.
MorphoSys is a German biopharmaceutical company developing antibody-based treatments for cancer and autoimmune diseases. It was acquired by Novartis in 2024.